Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Pharm Res. 2016 Jun 10;33(10):2400–2410. doi: 10.1007/s11095-016-1963-8

Fig. 1.

Fig. 1

a) Modular design of targeted, nanoscale imaging agents for early-stage disease detection and b) cartoon representation of tailored nanoparticles with 5, 10 and 25% CANF loading. Percentages refer to the feed ratio of the CANF-PEG monomers relative to the total PEG monomers.